,i  #aag? ,,congress  #b;d ,session  ,h4
 ,r4 #hgbd  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,augu/ #af1 #bjbb,mrs4
 ,c>olyn ,b4 ,maloney ( ,new ,york 7=   
h]self1 ,ms4 ,m5g1 ,ms4 ,adams1 ,ms4    
,b>ragn1 ,mr4 ,blum5au]1 ,mr4 ,c>son1   
,ms4 ,*u1 ,ms4 ,cl>ke ( ,new ,york1 ,mr4
 ,danny ,k4 ,davis ( ,ill9ois1 ,ms4     
,escob>1 ,mr4 ,khanna1 ,ms4 ,ku/]1 ,ms4 
,moore ( ,wiscons91 ,ms4 ,roybal-,all>d1
 ,ms4 ,s*ak[sky1 & ,ms4 ,velzquez7      
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce  ,a  
,,bill  ,to am5d ! ,public ,heal?       
,s]vice ,act to e/abli% a program (     
rese>* reg>d+ ! risks pos$ by ! pres5ce 
( diox9s1 ph?alates1 pe/icides1 *emical 
fragrances1 & o!r compon5ts ( m5/rual   
products & intimate c>e products4  #a4  
,%ort title ,?is ,act may be cit$ z !   
,rob9 ,danielson ,m5/rual ,product &    
,intimate ,c>e ,product ,safety ,act (  
#bjbb4  #b4 ,f9d+s ,! ,congress f9ds z  
foll[s3 7#a7 ,m5/rual products &        
intimate c>e products are widely us$ 9 !

 ,unit$ ,/ates today1 b !re is n en\gh  
rese>* on ! safety ( or pot5tial *emical
 exposure f compon5ts ( ^! products4    
7#b7 ,p :o m5/ruate may be expos$ to    
sub/ances 9 tampons & o!r m5/rual       
products = z long z #dj ye>s ov] ! c\rse
 ( _! reproductive lives4 ,! av]age     
p]son :o m5/ruates may use up to #af1jjj
 tampons 9 _! lifetime4  7#c7 ,trace    
am\nts ( diox9s c be f\nd 9 tampons &   
o!r m5/rual products4 ,! ,environm5tal  
,protection ,ag5cy & ! ,int]national    
,ag5cy = ,rese>* on ,canc]1 an arm ( !  
,_w ,heal? ,organization1 h conclud$ t  
diox9s are a probable human c>c9og5     
7canc]-caus+ ag5t74  7#d7 ,*emical te/+ 
( m5/rual products f ar\nd ! _w h       
detect$ sev]al additional *emicals (    
conc]n includ+ ph?alates1 volatile      
organic comp\nds1 pe/icides1 c>bon      
disulfide1 & p]-& polyfluoroalkyl       
sub/ances 7,,pfas74  7#e7 ,intimate c>e 
products frequ5tly conta9 undisclos$    
fragrance *emicals1 "s ( :i* may be     
all]g5s1 reproductive tox9s1 & c>c9og5s4

 ,su* products also conta9 pot5tially   
h>mful pres]vatives4 ,rese>* releas$ by 
,apo!rc>e1 ,wom5's ,voices = ! ,e>?1 &  
,black ,wom5 = ,wellness f\nd t "s      
intimate c>e products specifically      
inhibit ! gr[? ( lactobacillus1 a       
crucial type ( heal?y bact]ia f\nd 9 !  
vag9al microbiome4 ,disruption ( !      
vag9al microbiome c lead to significant 
heal? problems includ+ bact]ial         
vag9osis1 increas$ risk ( sexually      
transmitt$ diseases1 & f]tility conc]ns4
  7#f7 ,intimate c>e products           
7especially d\*es & p[d]s7 h be5        
associat$ ) high] levels ( toxic        
*emicals 9 ! bodies ( p :o use !m4      
,specifically1 ph?alate levels 9 ur9e 7 
significantly high] 9 p :o d\*e         
frequ5tly4 ,ano!r /udy f\nd             
significantly high] levels (            
#a1d-;di*lorob5z5e 9 ! blood ( p :o d\*e
 frequ5tly & high] levels ( e?ylb5z5e 9 
! blood ( intimate p[d] us]s4  7#g7     
,rese>* reg>d+ ! pres5ce ( *emicals 9   
m5/rual products & intimate c>e products

 plays a role 9 advanc+ heal? equity =  
populations t h hi/orically exp]i5c$    
heal? disp>ities1 includ+ ,black p4     
7#h7 ,regulatory ov]sight ( ! safety (  
mat]ials 9 m5/rual & intimate c>e       
products is limit$4 ,! ,food & ,drug    
,adm9i/ration has hi/orically reli$ on  
data provid$ by manufactur]s ( m5/rual  
products 9 det]m9+ product safety4      
,intimate c>e products g5]ally d n ne$  
approval by ! ,food & ,drug             
,adm9i/ration be=e !y g on ! m>ket1 &   
manufactur]s h ! responsibility to      
ensure ! safety ( _! products4  #c4     
,rese>* on diox9s & o!r pot5tially      
h>mful compon5ts ( m5/rual products &   
intimate c>e products ,"p ,f ( title    
,,iv ( ! ,public ,heal? ,s]vice ,act    
7#db ,u4,s4,c4 #bhg;d et seq47 is am5d$ 
by add+ at ! end ! foll[+ new section3  
#dhf;,c4 ,rese>* on diox9s & o!r        
pot5tially h>mful compon5ts ( m5/rual   
products & intimate c>e products  7a7   
,rese>*  7#a7 ,9 g5]al ,! ,director (   
,,nih %all provide = ! conduct or       

support ( rese>* to det]m9e ! ext5t to  
:i* ! pres5ce ( diox9s1 ph?alates1      
titanium dioxide1 & o!r compon5ts       
7includ+ contam9ants & sub/ances us$ z  
fragrances1 colorants1 dyes1 &          
pres]vatives7 9 tampons & o!r m5/rual   
products & intimate c>e products-- 7,a7 
poses any risks to ! heal? ( p :o use ! 
products1 includ+ risks relat$ to       
gynecologic1 brea/1 & o!r canc]s1       
endometriosis1 inf]tility & pregnancy   
outcomes1 immune sy/em defici5cies1     
pelvic inflammatory disease1 toxic %ock 
syndrome1 ! heal? ( ! vag9al microbiome1
 & o!r bact]ial & yea/ infections2 &    
7,b7 poses any risks to ! heal? ( *ildr5
 or p :o us$ su* products dur+ or be=e !
 pregnancies involv$1 includ+ risks     
relat$ to fetal & *ildhood developm5t4  
7#b7 ,def9ition ,= purposes ( p>agraph  
7#a7-- 7,a7 ! t]m m5/rual products means
 tampons1 pads1 l9]s1 cups1 sponges1 &  
simil> products us$ by p :o m5/ruate )  
respect to m5/ruation or o!r            
g5ital-tract secretions2 &  7,b7 ! t]m  

intimate c>e products means d\*es1      
wipes1 sprays1 wa%es1 p[d]s1 & simil>   
products us$ ) respect to vulva or      
vag9al cleans+4  7b7 ,au?orization (    
appropriations ,= ! purpose ( c>ry+ out 
?is section1 !re are au?oriz$ to be     
appropriat$ su* sums z may be necess>y =
 ea* ( ! fiscal ye>s #bjbc ?r\gh #bjbg4 
4